Tue, May 1, 2018

Travis Steed Maintained (AXGN) at Buy with Increased Target to $45 on, May 1st, 2018

Travis Steed of Cantor Fitzgerald, Maintained "AxoGen, Inc." (AXGN) at Buy with Increased Target from $37 to $45 on, May 1st, 2018.

Travis, nor any peers, have made any analyst calls on AXGN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30